Replies to post #39544 on PharmaCyte Biotech Inc (PMCB)

[rudygerner]

You are quite welcome. With the Cell-in-a-Box (CiaB) technology we have the best protection available to the cells which are encapsulated; nutrients are allowed in while byproducts are allowed to be released - all while protecting the encapsulated cells from being attacked by the human body's immune system. Furthermore, the CiaB encapsulation produces a "shell", if you will, around the cell which is robust enough to be able to withstand not only the injection process itself, but also to remain inside the human body for up to two years and then be completely and successfully removed. There exists no other technology in the world capable of claiming such abilities. I remain adamant that PMCB's pancreatic cancer treatment will serve as the proverbial shot across the bow; their diabetes treatment is going to be what gets PharmaCyte Biotech purchased by big pharma.

Here are some interesting links: http://patents.justia.com/patent/7083607

http://patents.justia.com/search?q=Salmons+and+Gunzburg

As you can see, Dr. Lohr and Dr. Gunzburg co-invented the injection device and the method for injecting the capsules. We are in very good hands.